Answers are grounded in this paper and cite their sources.
This study evaluated the in vitro activity of ceftaroline, a novel cephalosporin with broad-spectrum activity against gram-negative and -positive pathogens, against 4,151 recent clinical isolates collected in the United States. Ceftaroline was very potent against bacteria found in community- and hospital-acquired infections, including methicillin-resistant Staphylococcus aureus, multidrug-resistant Streptococcus pneumoniae, and common Enterobacteriaceae spp.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: